Published:
Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference
SAN DIEGO, Nov. 20 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.
(Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief
Executive Officer of Neurocrine Biosciences will be presenting at the 20th
Annual Piper Jaffray Health Care Conference inNew York.
The live "fireside chat" presentation takes place Tuesday, December 2,
2008 at 1:30 p.m. Eastern Time (ET) /10:30 a.m. Pacific Time (PT). The
presentation will be simultaneously webcast and may be accessed on the
Company's website at http://www.neurocrine.com.
If you are unable to attend the webcast and would like further information
on this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the
website approximately 5 minutes prior to the presentation to download or
install any necessary software. A replay of the presentation will be available
approximately three hours after the conclusion of the live event and will be
archived on the website for two weeks.
About Neurocrine
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on
neurological and endocrine diseases and disorders. Our product candidates
address some of the largest pharmaceutical markets in the world including
endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain,
diabetes, benign prostatic hyperplasia (BPH) and other neurological and
endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news
releases are available through the Company's website via the internet at
http://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.
Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,HEA,MTC,BIO,TDS,CCA,CA-NBIX-Piper-Jaffray
Search News
Daily News
